Menu
Currency
GWAS Study

Pleiotropy method reveals genetic overlap between orofacial clefts at multiple novel loci from GWAS of multi-ethnic trios.

Ray D, Venkataraghavan S, Zhang W et al.

34242216 PubMed ID
GWAS Study Type
10146 Participants
51 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

RD
Ray D
VS
Venkataraghavan S
ZW
Zhang W
LE
Leslie EJ
HJ
Hetmanski JB
WS
Weinberg SM
MJ
Murray JC
MM
Marazita ML
RI
Ruczinski I
TM
Taub MA
BT
Beaty TH
Chapter II

Abstract

Summary of the research findings

Based on epidemiologic and embryologic patterns, nonsyndromic orofacial clefts- the most common craniofacial birth defects in humans- are commonly categorized into cleft lip with or without cleft palate (CL/P) and cleft palate alone (CP), which are traditionally considered to be etiologically distinct. However, some evidence of shared genetic risk in IRF6, GRHL3 and ARHGAP29 regions exists; only FOXE1 has been recognized as significantly associated with both CL/P and CP in genome-wide association studies (GWAS). We used a new statistical approach, PLACO (pleiotropic analysis under composite null), on a combined multi-ethnic GWAS of 2,771 CL/P and 611 CP case-parent trios. At the genome-wide significance threshold of 5 × 10-8, PLACO identified 1 locus in 1q32.2 (IRF6) that appears to increase risk for one OFC subgroup but decrease risk for the other. At a suggestive significance threshold of 10-6, we found 5 more loci with compelling candidate genes having opposite effects on CL/P and CP: 1p36.13 (PAX7), 3q29 (DLG1), 4p13 (LIMCH1), 4q21.1 (SHROOM3) and 17q22 (NOG). Additionally, we replicated the recognized shared locus 9q22.33 (FOXE1), and identified 2 loci in 19p13.12 (RAB8A) and 20q12 (MAFB) that appear to influence risk of both CL/P and CP in the same direction. We found locus-specific effects may vary by racial/ethnic group at these regions of genetic overlap, and failed to find evidence of sex-specific differences. We confirmed shared etiology of the two OFC subtypes comprising CL/P, and additionally found suggestive evidence of differences in their pathogenesis at 2 loci of genetic overlap. Our novel findings include 6 new loci of genetic overlap between CL/P and CP; 3 new loci between pairwise OFC subtypes; and 4 loci not previously implicated in OFCs. Our in-silico validation showed PLACO is robust to subtype-specific effects, and can achieve massive power gains over existing approaches for identifying genetic overlap between disease subtypes. In summary, we found suggestive evidence for new genetic regions and confirmed some recognized OFC genes either exerting shared risk or with opposite effects on risk to OFC subtypes.

300 Asian ancestry cleft lip trios, 299 European ancestry cleft lip trios, 89 Latin American cleft lip trios, 6 cleft lip trios, 875 Asian ancestry cleft lip with cleft palate trios, 679 European ancestry cleft lip with cleft palate trios, 508 Latin American cleft lip with cleft palate trios, 15 cleft lip with cleft palate trios, 273 Asian ancestry cleft palate trios, 296 European ancestry cleft palate trios, 28 Latin American cleft palate trios, 14 cleft palate trios

Chapter III

Study Statistics

Key metrics and study information

10146
Total Participants
GWAS
Study Type
No
Replicated
Asian unspecified, European, Hispanic or Latin American
Ancestry
China, Philippines, Republic of Korea, Singapore, Taiwan, Denmark, Norway, U.S.
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.